|
|
Article: Prescription Drug Advertising Enters Critical New Phase; Brand Development will Require More Astute Direct-to-Consumer Campaigns, cautions Ipsos.
- Article from:
- PR Newswire
- Article date:
- January 27, 2004
CopyrightCOPYRIGHT 2004 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
NEW YORK, NY, Jan. 27 /PRNewswire/ -- Direct-to-consumer (DTC) prescription drug (Rx) advertising is at a crossroads, according to Ipsos PharmTrends(R), a syndicated service tracking consumer purchase behavior of both prescription and over-the-counter (OTC) drugs provided by Ipsos, the global marketing research firm. After seven years of strong growth, both advertising expenditures and consumer response have leveled off, the company says.
"Now that the spending spree has reached a plateau, marketers will have to carefully scrutinize their promotional plans - and apply lessons learned - if they are to successfully meet the challenges ahead," noted Fariba ...
Related newspaper, magazine, and journal articles:
|
|
Article: Prescription Drug Ads Prompt Consumers to Seek More Information ...
PR Newswire;
October 9, 2002 ;
700+ words
... ... said Fariba Zamaniyan, Director, Ipsos PharmTrends(R) . Certain brand name prescription ... contact: Fariba Zamaniyan, Director, Ipsos PharmTrends(R), 516-507-3047, fariba ... CONTACT: Fariba Zamaniyan, Director, Ipsos PharmTrends(R), 516-507-3047, fariba ...
|
|